The Meharry-Vanderbilt-Tennessee State Cancer Partnership (MVTCP) recently hosted its 23rd Annual Symposium on February 10, 2024, showcasing innovative cancer research and fostering collaboration among primary investigators (PIs) and research students. The MVTCP is the longest running cancer research collaboration between three institutions, to date. The symposium boasted an impressive lineup of speakers, including the distinguished
Cristen Flewellen, a second-year Meharry medical student, was awarded Third Place in the Community Research category at the 67th Annual Meharry Student Research Day for her work with the Breast cancer Risk Assessment- achieVing Equity (BRAVE) study funded through the Meharry Vanderbilt Tennessee State Cancer Partnership (MVTCP). The BRAVE study PIs are Lucy Spalluto, MD
The meeting theme: “Building on a Solid Foundation to Strategically Strengthen and Enhance PACHE.” The gathering brought together PACHE (U54/P20) investigators, Program Managers, and NCI/CRCHD staff to discuss progress made by the program as well as topics that are important for the continued growth of PACHE. Photo of MVTCP Leadership: C. Whitted(MVA), L. Stewart(MMC), A.
The Community Outreach Core (COC) of the Meharry Vanderbilt Tennessee State Cancer Partnership (MVTCP) has updated the request for support services online form. If you have questions or needs, the expert faculty of the COC is available for consultation. Use the link below to complete the request form: https://redcap.link/osixjxly
Meharry-Vanderbilt-Tennessee State University Cancer Partnership (MVTCP): Vanderbilt Medical Cancer Research Experience (please see attached pdf) Only Vanderbilt medical students are eligible, but they can work with any MVTCP investigator. $3K to support research activities (including attendance at a scientific meeting) Short application required: https://redcap.link/MVTCP23-24
A new study authored by Vishal R. Patel, BS, Dr. Alex B. Haynes, MD, MPH (Dell Medical School, The University of Texas at Austin), Dr. Karen Winkfield, M.D., PhD (Meharry-Vanderbilt Alliance, Vanderbilt University Medical Center, Nashville, TN), Dr. Arjun Gupta, MD, Dr. Anne H. Blaes, MD, MS (Masonic Cancer Center, University of Minnesota, Minneapolis), Dr.
Dr. Kunle Odunsi, MD, PhD,a new member of the Meharry Vanderbilt Tennessee State Cancer Partnership (MVTCP) Program Steering Committee, will present at the upcoming Flexner Discovery Lecture, hosted by theVanderbilt-Ingram Cancer Center (VICC) Medical Scientist Training Program. Dr. Odunsi is the Director of the Comprehensive Cancer Center, Dean for Oncology, and AbbVie Distinguished Service Professor
